S. 1416

To amend the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.

Senate · 2 versions on the shelf

Print stage	Date	Size	⠃
Introduced in Senate	2019-05-09	21.9K	⠃⠗⠋
Reported in Senate	2019-06-28	38.9K	⠃⠗⠋